| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-86095-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-89515-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-15180SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-86504-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76557-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-49635-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89286-50ul | |||
![Immunohistochemistry-Paraffin: pIgR Antibody [NBP1-86095] - Analysis in human duodenum and skeletal muscle tissues. Corresponding PIGR RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/pIgR-Antibody-Immunohistochemistry-Paraffin-NBP1-86095-img0011.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: pIgR Antibody [NBP1-86095] - Analysis in human duodenum and skeletal muscle tissues. Corresponding PIGR RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: pIgR Antibody [NBP1-86095] - Staining of human tonsil shows no positivity in non-germinal center cells as expected.](http://images.novusbio.com/fullsize/pIgR-Antibody-Immunohistochemistry-Paraffin-NBP1-86095-img0014.jpg)
![Immunohistochemistry-Paraffin: pIgR Antibody [NBP1-86095] - Staining of human duodenum shows strong cytoplasmic and membranous positivity in glandular cells.](http://images.novusbio.com/fullsize/pIgR-Antibody-Immunohistochemistry-Paraffin-NBP1-86095-img0012.jpg)
![Immunohistochemistry-Paraffin: pIgR Antibody [NBP1-86095] - Staining of human kidney shows moderate cytoplasmic positivity in cells in tubules.](http://images.novusbio.com/fullsize/pIgR-Antibody-Immunohistochemistry-Paraffin-NBP1-86095-img0013.jpg)
![Immunohistochemistry-Paraffin: pIgR Antibody [NBP1-86095] - Staining of human skeletal muscle shows no positivity in myocytes as expected.](http://images.novusbio.com/fullsize/pIgR-Antibody-Immunohistochemistry-Paraffin-NBP1-86095-img0015.jpg)
![Western Blot: IFIT2 Antibody [NBP1-31164] - p115 and Sec16A are required for optimal IRF-3 activation in response to activation of cytosolic RNA and DNA sensors.HeLa cells were infected with lentiviral vectors encoding shRNA targeting p115. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.ppat.1002747) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/IFIT2-Antibody-Western-Blot-NBP1-31164-img0006.jpg "Western Blot: IFIT2 Antibody [NBP1-31164] - p115 and Sec16A are required for optimal IRF-3 activation in response to activation of cytosolic RNA and DNA sensors.HeLa cells were infected with lentiviral vectors encoding shRNA targeting p115. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.ppat.1002747) licensed under a CC-BY license.")
![Western Blot: IFIT2 Antibody [NBP1-31164] - Sample(30 ug of whole cell lysate)A:A431 B:Hep G2 7.5% SDS PAGE, antibody diluted at 1:1000.](http://images.novusbio.com/fullsize/IFIT2-Antibody-Western-Blot-NBP1-31164-img0003.jpg)
![Western Blot: IFIT2 Antibody [NBP1-31164] - p115 & Sec16A are required for optimal IRF-3 activation in response to activation of cytosolic RNA & DNA sensors.HeLa cells were infected with lentiviral vectors encoding shRNA targeting p115 (A) or Sec16A (B) & non-targeting (NT) control shRNA for 24 h followed by puromycin selection (1.5 µg/ml) for 5 days. Cells were left untreated or stimulated with poly I:C (1 µg/ml), poly dA:dT (1 µg/ml) or SeV (200 HAU/ml) for 16 h. Whole-cell lysates were prepared & subjected to immunoblot analysis with indicated antibodies. One of two independent experiments with similar results is shown. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/22792062), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-31164_rabbit-polyclonal-ifit2-antibody-310202415171321.jpg)
![IFIT2 antibody [N1], N-term detects IFIT2 protein at endoplasmic reticulum by immunofluorescent analysis.Sample: HeLa cells were fixed in 4% paraformaldehyde at RT for 15 min.Green: IFIT2 protein stained by IFIT2 antibody [N1], N-term (NBP1-31164) diluted at 1:200.Red: alpha Tubulin, a cytoskeleton marker, stained by alpha Tubulin antibody [B-5-1-2] diluted at 1:10000.Blue: Hoechst 33342 staining.](http://images.novusbio.com/fullsize/nbp1-31164_rabbit-polyclonal-ifit2-antibody-immunocytochemistry-immunofluorescence-1411202518351210.jpg)
![Immunocytochemistry/Immunofluorescence: MDH1 Antibody [NBP1-89515] - Staining of human cell line U-251 MG shows localization to cytosol & centrosome. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/MDH1-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-89515-img0007.jpg "Immunocytochemistry/Immunofluorescence: MDH1 Antibody [NBP1-89515] - Staining of human cell line U-251 MG shows localization to cytosol & centrosome. Antibody staining is shown in green.")
![Western Blot: IFIT2 Antibody [NBP2-15180] - MAPL is required for early steps of immune response to Sendai virus infection. Maplfl/fl and Mapl-/- MEFs were left untreated or infected with Sendai virus (150 HAU/mL) for up to 18 hours and lysates were immunoblotted. Image collected and cropped by CiteAb from the following publication (//www.nature.com/articles/s41598-017-00151-6), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/IFIT2-Antibody-Western-Blot-NBP2-15180-img0004.jpg "Western Blot: IFIT2 Antibody [NBP2-15180] - MAPL is required for early steps of immune response to Sendai virus infection. Maplfl/fl and Mapl-/- MEFs were left untreated or infected with Sendai virus (150 HAU/mL) for up to 18 hours and lysates were immunoblotted. Image collected and cropped by CiteAb from the following publication (//www.nature.com/articles/s41598-017-00151-6), licensed under a CC-BY license.")
![Immunocytochemistry/Immunofluorescence: IFIT2 Antibody [NBP2-15180] - SK-MEL-28 cells were fixed for 10 minutes using 10% formalin and then permeabilized for 5 minutes using 1X PBS + 0.05% Triton-X100. The cells were incubated with anti-IFIT2 at 10 ug/ml overnight at 4C and detected with an anti-rabbit Dylight 488 (Green) at a 1:500 dilution. Nuclei were counterstained with DAPI (Blue). Cells were imaged using a 40X objective.](http://images.novusbio.com/fullsize/IFIT2-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-15180-img0003.jpg)
![Western Blot: IFIT2 Antibody [NBP2-15180] - Analysis of IFIT2 in human K562 lysate in the 1) absence and 2) presence of immunizing peptide, and 3) mouse RAW lysate probed with 4 ug/ml of IFIT2 antibody. Goat anti-rabbit Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.](http://images.novusbio.com/fullsize/IFIT2-Antibody-Western-Blot-NBP2-15180-img0002.jpg)
![Western Blot: MDH1 Antibody (JE35-03) [NBP3-32582] - Western blot analysis of MDH1 on different lysates with Rabbit anti-MDH1 antibody (NBP3-32582) at 1/1,000 dilution. Lane 1: Jurkat cell lysate (20 ug/Lane) Lane 2: HepG2 cell lysate (20 ug/Lane) Lane 3: U-937 cell lysate (20 ug/Lane) Lane 4: HL-60 cell lysate (20 ug/Lane) Lane 5: NIH/3T3 cell lysate (20 ug/Lane) Lane 6: Rat kidney tissue lysate (40 ug/Lane) Predicted band size: 36 kDa Observed band size: 35 kDa Exposure time: 6 seconds; ECL; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (NBP3-32582) at 1/1,000 dilution was used in 5% NFDM/TBST at 4 overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1/50,000 dilution was used for 1 hour at room temperature.](http://images.novusbio.com/fullsize/nbp3-32582_rabbit-mdh1-mab-je35-03-278202416331296.jpg)
![Immunocytochemistry/ Immunofluorescence: MDH1 Antibody (JE35-03) [NBP3-32582] - Immunocytochemistry analysis of U-937 cells labeling MDH1 with Rabbit anti-MDH1 antibody (NBP3-32582) at 1/100 dilution. Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-MDH1 antibody (NBP3-32582) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI. Beta tubulin (red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594) was used as the secondary antibody at 1/1,000 dilution.](http://images.novusbio.com/fullsize/nbp3-32582_rabbit-mdh1-mab-je35-03-2920241114837.jpg)
![Flow Cytometry: MDH1 Antibody (JE35-03) [NBP3-32582] - Flow cytometric analysis of U-937 cells labeling MDH1. Cells were fixed and permeabilized. Then stained with the primary antibody (NBP3-32582, 1μg/mL) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).](http://images.novusbio.com/fullsize/nbp3-32582_rabbit-mdh1-mab-je35-03-392024884643.jpg)
![Immunohistochemistry-Paraffin: pIgR Antibody [NBP1-32897] - Paraffin-embedded human lung adenocarcinoma. PIGR antibody [N2C1], Internal diluted at 1:500.](http://images.novusbio.com/fullsize/pIgR-Antibody-Immunohistochemistry-Paraffin-NBP1-32897-img0005.jpg "Immunohistochemistry-Paraffin: pIgR Antibody [NBP1-32897] - Paraffin-embedded human lung adenocarcinoma. PIGR antibody [N2C1], Internal diluted at 1:500.")
![Immunohistochemistry-Paraffin: pIgR Antibody [NBP1-32897] - Paraffin-embedded Cal27 xenograft, using antibody at 1:500 dilution.](http://images.novusbio.com/fullsize/pIgR-Antibody-Immunohistochemistry-Paraffin-NBP1-32897-img0007.jpg)
![HepG2 cells were fixed in 4% paraformaldehyde at RT for 15 min. Green: PIGR stained by PIGR antibody [N2C1], Internal diluted at 1:500.Blue: Fluoroshield with DAPI. Scale bar= 10 μm.](http://images.novusbio.com/fullsize/antibody/nbp1-32897_rabbit-polyclonal-pigr-antibody-immunocytochemistry-immunofluorescence-273202392020.jpg)
![Human milk (30 ug) was separated by 7.5% SDS-PAGE, and the membranes were blotted with PIGR antibody [N2C1], Internal (NBP1-32897) diluted at 1:50000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody](http://images.novusbio.com/fullsize/nbp1-32897_rabbit-polyclonal-pigr-antibody-western-blot-261120251849132.jpg)
![Immunohistochemistry-Paraffin: pIgR Antibody [NBP1-86504] - Analysis in human colon and placenta tissues using NBP1-86504 antibody. Corresponding PIGR RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/pIgR-Antibody-Immunohistochemistry-Paraffin-NBP1-86504-img0007.jpg "Immunohistochemistry-Paraffin: pIgR Antibody [NBP1-86504] - Analysis in human colon and placenta tissues using NBP1-86504 antibody. Corresponding PIGR RNA-seq data are presented for the same tissues.")
![Immunohistochemistry-Paraffin: pIgR Antibody [NBP1-86504] - Staining of human colon shows strong cytoplasmic positivity in glandular cells.](http://images.novusbio.com/fullsize/pIgR-Antibody-Immunohistochemistry-Paraffin-NBP1-86504-img0008.jpg)
![Immunohistochemistry-Paraffin: pIgR Antibody [NBP1-86504] - Staining of human placenta shows no cytoplasmic positivity in trophoblastic cells as expected.](http://images.novusbio.com/fullsize/pIgR-Antibody-Immunohistochemistry-Paraffin-NBP1-86504-img0009.jpg)
![Immunohistochemistry-Paraffin: pIgR Antibody [NBP1-86504] - Staining of human skin shows no cytoplasmic positivity in squamous epithelial cells as expected.](http://images.novusbio.com/fullsize/pIgR-Antibody-Immunohistochemistry-Paraffin-NBP1-86504-img0011.jpg)
![Immunohistochemistry: IFIT2 Antibody - BSA Free [NBP3-46052] - Immunohistochemistry of paraffin-embedded human kidney tissue slide using (IFIT2 Antibody) at dilution of 1:50](http://images.novusbio.com/fullsize/nbp3-46052_rabbit-ifit2-pab-bsa-free-28420251155450.jpg "Immunohistochemistry: IFIT2 Antibody - BSA Free [NBP3-46052] - Immunohistochemistry of paraffin-embedded human kidney tissue slide using (IFIT2 Antibody) at dilution of 1:50")
![Immunocytochemistry/ Immunofluorescence: IFIT2 Antibody - BSA Free [NBP3-46052] - Immunofluorescent analysis of HepG2 cells using (IFIT2 antibody) at dilution of 1:25 and Alexa Fluor 488-conjugated Goat Anti-Rabbit IgG(H+L)](http://images.novusbio.com/fullsize/nbp3-46052_rabbit-ifit2-pab-bsa-free-284202511474555.jpg)
![Western Blot: IFIT2 Antibody - BSA Free [NBP3-46052] - A431 cells were subjected to SDS PAGE followed by western blot with (IFIT2 Antibody) at dilution of 1:300](http://images.novusbio.com/fullsize/nbp3-46052_rabbit-ifit2-pab-bsa-free-284202511463192.jpg)
![Western Blot: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody [NBP1-76557] - 293 cell lysate with Lymphocyte Antigen 9 antibody at (A) 1 and (B) 2 ug/mL.](http://images.novusbio.com/fullsize/CD229-SLAMF3-Lymphocyte-Antigen-9-Antibody-Western-Blot-NBP1-76557-img0001.jpg "Western Blot: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody [NBP1-76557] - 293 cell lysate with Lymphocyte Antigen 9 antibody at (A) 1 and (B) 2 ug/mL.")
![Immunocytochemistry/ Immunofluorescence: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody - BSA Free [NBP1-76557] - Immunocytochemistry of CD229/SLAMF3/Lymphocyte Antigen 9 in 293 cells with CD229/SLAMF3/Lymphocyte Antigen 9 antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76557_rabbit-polyclonal-cd229-slamf3-lymphocyte-antigen-9-antibody-271120242042544.jpg)
![Immunocytochemistry/ Immunofluorescence: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody - BSA Free [NBP1-76557] - Immunofluorescence of CD229/SLAMF3/Lymphocyte Antigen 9 in 293 cells with CD229/SLAMF3/Lymphocyte Antigen 9 antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76557_rabbit-polyclonal-cd229-slamf3-lymphocyte-antigen-9-antibody-2711202419313292.jpg)
![Flow Cytometry: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody (HLy9.25) [NBP1-50070] - Surface staining of human peripheral blood cells with anti-human CD229 (HLy9.25) PE.](http://images.novusbio.com/fullsize/CD229-SLAMF3-Lymphocyte-Antigen-9-Antibody-HLy9-25-Flow-Cytometry-NBP1-50070-img0002.jpg "Flow Cytometry: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody (HLy9.25) [NBP1-50070] - Surface staining of human peripheral blood cells with anti-human CD229 (HLy9.25) PE.")
![Flow Cytometry: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody (HLy9.25) [NBP1-50070] - Surface staining of human peripheral blood cells with anti-human CD229 (HLy9.25) APC.](http://images.novusbio.com/fullsize/CD229-SLAMF3-Lymphocyte-Antigen-9-Antibody-HLy9-25-Flow-Cytometry-NBP1-50070-img0001.jpg)
![Immunohistochemistry-Paraffin: CD84/SLAMF5 Antibody [NBP2-49635] -Staining of human colon shows strong cytoplasmic positivity in mast cells.](http://images.novusbio.com/fullsize/antibody/nbp2-49635_rabbit-polyclonal-cd84-slamf5-antibody-immunohistochemistry-paraffin-273202494914..jpg "Immunohistochemistry-Paraffin: CD84/SLAMF5 Antibody [NBP2-49635] -Staining of human colon shows strong cytoplasmic positivity in mast cells.")
![Immunohistochemistry-Paraffin: CD84/SLAMF5 Antibody [NBP2-49635] -Staining of human placenta shows no cytoplasmic positivity in trophoblastic cells as expected.](http://images.novusbio.com/fullsize/antibody/nbp2-49635_rabbit-polyclonal-cd84-slamf5-antibody-immunohistochemistry-paraffin-27320249507..jpg)
![Immunohistochemistry-Paraffin: CD84/SLAMF5 Antibody [NBP2-49635] - Staining of human pancreas shows no cytoplasmic positivity in exocrine glandular cells as expected.](http://images.novusbio.com/fullsize/antibody/nbp2-49635_rabbit-polyclonal-cd84-slamf5-antibody-immunohistochemistry-paraffin-273202495058..jpg)
![Immunohistochemistry-Paraffin: CD84/SLAMF5 Antibody [NBP2-49635] -Staining of human skeletal muscle shows no cytoplasmic positivity in myocytes as expected.](http://images.novusbio.com/fullsize/antibody/nbp2-49635_rabbit-polyclonal-cd84-slamf5-antibody-immunohistochemistry-paraffin-273202495212..jpg)
![Immunocytochemistry/Immunofluorescence: pIgR Antibody (007) [NBP2-89286] - Staining of PIGR in HepG2 cells. Cells were fixed with 4% PFA,blocked with 10% serum, and incubated with rabbit anti-Y PIGR monoclonal antibody (dilution ratio 1:60) at 4c overnight. Then cells were stained with the Alexa Fluor (R)488-conjugated Goat Anti-rabbit IgG secondary antibody (green) and counterstained with DAPI (blue).Positive staining was localized to Cytoplasm.](http://images.novusbio.com/fullsize/pIgR-Antibody-007-Immunocytochemistry-Immunofluorescence-NBP2-89286-img0003.jpg "Immunocytochemistry/Immunofluorescence: pIgR Antibody (007) [NBP2-89286] - Staining of PIGR in HepG2 cells. Cells were fixed with 4% PFA,blocked with 10% serum, and incubated with rabbit anti-Y PIGR monoclonal antibody (dilution ratio 1:60) at 4c overnight. Then cells were stained with the Alexa Fluor (R)488-conjugated Goat Anti-rabbit IgG secondary antibody (green) and counterstained with DAPI (blue).Positive staining was localized to Cytoplasm.")
![Immunohistochemistry-Paraffin: pIgR Antibody (007) [NBP2-89286] - Staining of human PIGR in human liver (cirrhosis) with rabbit monoclonal antibody (1:60). Positive staining was localized to hepatocyte.](http://images.novusbio.com/fullsize/pIgR-Antibody-007-Immunohistochemistry-Paraffin-NBP2-89286-img0002.jpg)
![Immunohistochemistry-Paraffin: pIgR Antibody (007) [NBP2-89286] - Staining of human PIGR in human breast carcinoma with rabbit monoclonal antibody (1:60).](http://images.novusbio.com/fullsize/pIgR-Antibody-007-Immunohistochemistry-Paraffin-NBP2-89286-img0001.jpg)